Diagnosis, Treatment and Follow Up of Acute Pulmonary Embolism: Consensus Practice from the PERT Consortium.
Belinda N Rivera-LebronMichael McDanielKamran AhrarAbdulah AlrifaiDavid M DudzinskiChristina FanolaDanielle BlaisDavid JanickeRoman MelamedKerry MohrienElizabeth RozyckiCharles B RossAndrew J KleinParth RaliNicholas R TemanLeoara YarboroEugene IchinoseAditya M SharmaJason A BartosMahir ElderBrent KeelingHarold PalevskySoophia NaydenovParijat SenNancy AmorosoJosanna M Rodriguez-LopezGeorge A DavisRachel RosovskyKenneth RosenfieldChristopher KabrhelJames HorowitzJay S GiriVictor TapsonRichard Channicknull nullPublished in: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis (2019)
Pulmonary embolism (PE) is a life-threatening condition and a leading cause of morbidity and mortality. There have been many advances in the field of PE in the last few years, requiring a careful assessment of their impact on patient care. However, variations in recommendations by different clinical guidelines, as well as lack of robust clinical trials, make clinical decisions challenging. The Pulmonary Embolism Response Team Consortium is an international association created to advance the diagnosis, treatment, and outcomes of patients with PE. In this consensus practice document, we provide a comprehensive review of the diagnosis, treatment, and follow-up of acute PE, including both clinical data and consensus opinion to provide guidance for clinicians caring for these patients.
Keyphrases
- pulmonary embolism
- inferior vena cava
- clinical trial
- clinical practice
- liver failure
- primary care
- healthcare
- palliative care
- newly diagnosed
- end stage renal disease
- ejection fraction
- chronic kidney disease
- type diabetes
- adipose tissue
- randomized controlled trial
- combination therapy
- open label
- deep learning
- replacement therapy
- glycemic control
- phase ii
- phase iii